Priority 19 from the Blood Transfusion and Blood Donation PSP

UNCERTAINTY: At what haemoglobin level [blood count] should a patient who has experienced a haematological (blood or bone marrow) disorder receive a blood transfusion? (JLA PSP Priority 19)
Overall ranking 19
JLA question ID 0063/19
Explanatory note Not available for this PSP


No systematic review evidence available
Health Research Classification System category Generic Health Relevance
Extra information provided by this PSP
Original uncertainty examples Patients with cancer/haematological malignancies/leukaemia/MDS, and production failure, what are the optimal red cell transfusion strategies? ~ Does transfusion to a haemoglobin >100 or >110 or >120 improve the quality of life of MDS patients? ~ What is the optimal red cell transfusion threshold for patients with acute leukaemia receiving intensive treatment?
Submitted by 1 relative or carer of blood recipient ~ 3 blood donors ~ 4 health professionals ~ 1 other (question not from survey)
PSP information
PSP unique ID 0063
PSP name Blood Transfusion and Blood Donation
Total number of uncertainties identified by this PSP 51  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop 28 February 2018